Fundraising Fox

Justin Kao

Investor

Partner at DFJ

San Francisco Bay Area

Writes $100K – $5M checks · typically $1.5M

About

Justin Kao is a partner at DFJ Growth who invests in companies transforming human health. He co-founded Helix in 2015, serving as founding CEO and later chief business officer, where he led partnerships with health systems, payers, and life sciences companies and worked on the company's COVID-19 diagnostic testing efforts. Before DFJ Growth, he was a partner at Khosla Ventures and an investor at Warburg Pincus, and earlier worked at Boston Consulting Group and Onyx Pharmaceuticals. He holds a BS in chemical engineering and MS in bioengineering from Stanford, plus a JD from Stanford Law School and an MBA from Stanford Graduate School of Business.

Invests in

AI & Machine LearningBiotechDeep TechDigital HealthHealthtech

Experience

  1. DFJ GrowthPartnercurrent2021 — presentSan Francisco Bay Area
  2. Khosla VenturesPartner2020 — 2021San Francisco Bay Area
  3. HelixCo-Founder and Chief Business Officer2015 — 2020San Mateo, CA
  4. Warburg PincusVice President, Healthcare2010 — 2015New York, San Francisco
  5. Onyx PharmaceuticalsIntern, Corporate Development2009
  6. Cooley Godward Kronish LLPSummer Associate2008
  7. The Boston Consulting GroupAssociate2005 — 2007

Education

  1. Stanford University Graduate School of BusinessMBA, Business
  2. Stanford Law SchoolJD, Law
  3. Stanford UniversityMS, Bioengineering
  4. Stanford UniversityBS, Chemical Engineering

Skills & more

Valuation12Mergers & Acquisitions18Private Equity25Lifesciences2Oncology4Analysis5Financial Modeling8Competitive Analysis9Corporate Development17Due Diligence12Leadership7Management12
+9 moreBiotechnologyInvestmentsStrategyCommercializationMergersLife SciencesVenture CapitalDesignMergers & Acquisitions (M&A)

From Justin's professional profile.

Same school

Shared employers

Deals · 3

Delfi Diagnostics, Inc.Board seat

via DFJ · filed Dec 2025 · $60M raise

InflammatixBoard seat

via DFJ · filed Mar 2021 · $102.4M raise

EarliBoard seat

via DFJ · filed Jan 2021 · $40M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at DFJ